KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Globus Medical (GMED) Equity Ratio (2016 - 2025)

Globus Medical (GMED) has disclosed Equity Ratio for 15 consecutive years, with 0.86 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Equity Ratio rose 7.89% year-over-year to 0.86, compared with a TTM value of 0.86 through Sep 2025, up 7.89%, and an annual FY2024 reading of 0.8, up 1.19% over the prior year.
  • Equity Ratio was 0.86 for Q3 2025 at Globus Medical, roughly flat from 0.87 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.9 in Q1 2021 and bottomed at 0.78 in Q3 2023.
  • Average Equity Ratio over 5 years is 0.86, with a median of 0.89 recorded in 2022.
  • The sharpest move saw Equity Ratio fell 12.41% in 2023, then increased 9.37% in 2025.
  • Year by year, Equity Ratio stood at 0.89 in 2021, then fell by 0.04% to 0.89 in 2022, then decreased by 11.61% to 0.79 in 2023, then grew by 1.19% to 0.8 in 2024, then grew by 8.53% to 0.86 in 2025.
  • Business Quant data shows Equity Ratio for GMED at 0.86 in Q3 2025, 0.87 in Q2 2025, and 0.87 in Q1 2025.